NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£1
Sector
HEALTH
Published
20 Jan 2025
Delivery
not specified
Deadline
n/a

Concepts

Location

United Kingdom: ITT lists participating authorities

Geochart for 1 buyers and 19 suppliers

1 buyer

7 suppliers

Description

NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinOffer reference number: CM/PHS/23/5703The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinOffer reference number: CM/PHS/23/5703Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.

Lot Division

1 Low and High Strength Albumin
2 5% Intravenous Immunoglobulin
3 10% Intravenous Immunoglobulin
4 Subcutaneous Immunoglobulin
5 Facilitated Subcutaneous Immunoglobulin
6 Anti-D Immunoglobulin

Award Detail

1 CSL Behring (Haywards Heath)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-1
  • Value: £1
2 Grifols UK Diagnostics (London)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-2
  • Value: £1
3 Octapharma (Manchester)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-3
  • Value: £1
4 Takeda (London)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-4
  • Value: £1
5 Grifols UK Diagnostics (London)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-5
  • Value: £1
6 Octapharma (Manchester)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-6
  • Value: £1
7 CSL Behring (Haywards Heath)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-7
  • Value: £1
8 Bio Products Laboratory (Elstree)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-8
  • Value: £1
9 Takeda (London)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-9
  • Value: £1
10 Grifols UK Diagnostics (London)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-10
  • Value: £1
11 Octapharma (Manchester)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-11
  • Value: £1
12 LFB Biomedicaments (Les Ulis)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-12
  • Value: £1
13 CSL Behring (Haywards Heath)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-13
  • Value: £1
14 Takeda (London)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-14
  • Value: £1
15 Grifols UK Diagnostics (London)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-15
  • Value: £1
16 Octapharma (Manchester)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-16
  • Value: £1
17 Takeda (London)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-17
  • Value: £1
18 CSL Behring (Haywards Heath)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-18
  • Value: £1
19 Bio Products Laboratory (Elstreee)
  • NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
  • Reference: 001899-2025-19
  • Value: £1

Award Criteria

price _

CPV Codes

  • 33651520 - Immunoglobulins

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** Out of the awarded suppliers, they were either awarded a committed market share or designated as reserve status with no committed market share. Further information on committed or reserve status by Lot is shown below:Lot 1Awarded Supplier - CSL, GrifolsReserve Supplier - OctapharmaLot 2Awarded Supplier - OctapharmaReserve Supplier - Grifols, TakedaLot 3Awarded Supplier - Grifols, Octapharma, TakedaReserve Supplier - BPL, CSL, LFBLot 4Awarded Supplier - Grifols, Octapharma, TakedaReserve Supplier - CSLLot 5Awarded Supplier - TakedaReserve Supplier – N/ALot 6 Awarded Supplier - CSLReserve Supplier - BPL

Reference

Domains